Life Science REIT PLC Capital Reinvestment Ratio
Life Science REIT PLC capital reinvestment ratio. Life Science REIT PLC (LABS) has a Capital Reinvestment Ratio of 6.06x as of June 2025, meaning it reinvests 6% of its operating cash flow (GBX958.00K) in capital expenditures (GBX5.81 Million). Check Life Science REIT PLC investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Life Science REIT PLC (2021–2024)
Capital reinvestment ratio of Life Science REIT PLC from 2021 to 2024. This chart tracks Life Science REIT PLC's Capital Reinvestment Ratio across 3 annual periods. Also explore net asset momentum of Life Science REIT PLC to track the company's year-over-year net asset growth rate.
Life Science REIT PLC Capital Reinvestment Ratio by Year (2021–2024)
Life Science REIT PLC capital reinvestment ratio by year from 2021 to 2024. For the full cash flow conversion analysis, see LABS cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.49x | GBX12.92 Million | GBX19.28 Million | ▼ -52.7% |
| 2023 | 3.16x | GBX7.62 Million | GBX24.03 Million | ▲ +46.1% |
| 2021 | 2.16x | GBX3.54 Million | GBX7.64 Million | — |